Maternal intravenous immunoglobulin for the prevention of allo-immune fetal and neonatal haemochromatosis

Document first published:
Page updated:
Topic:
Publication type:
,

NHS England will commission maternal intravenous immunoglobulin (IVIg) for the prevention of allo-immune fetal and neonatal haemochromatosis in accordance with the criteria outlined in this policy.

Document

Clinical Commissioning Policy: Maternal intravenous immunoglobulin for the prevention of allo-immune fetal and neonatal haemochromatosis

Clinical Commissioning Policy: Maternal intravenous immunoglobulin for the prevention of allo-immune fetal and neonatal haemochromatosis

  • PDF
  • 454 KB
  • 19 pages

Document

Consultation Report

Consultation Report

  • PDF
  • 40 KB
  • 2 pages

Document

Evidence Review

Evidence Review

  • PDF
  • 284 KB
  • 25 pages

Document

Stakeholder Engagement Report

Stakeholder Engagement Report

  • PDF
  • 36 KB
  • 2 pages

Document

Clinical Panel Report

Clinical Panel Report

  • PDF
  • 39 KB
  • 2 pages

Document

CPAG Summary Report

CPAG Summary Report

  • PDF
  • 122 KB
  • 8 pages